Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China · Delayed Price · Currency is CNY 31.98
+0.25 (0.79%)
At close: Sep 30, 2026
Bright Eye Hospital Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,761 | 4,896 | 6,982 | 12,867 | 10,563 | - | |
Market Cap Growth | -12.74% | -29.87% | -45.74% | 21.81% | - | - |
Enterprise Value | 6,296 | 6,400 | 8,277 | 13,800 | 10,654 | - |
Last Close Price | 31.98 | 32.58 | 46.46 | 84.27 | 69.11 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 380.28 | - | - | 48.03 | 513.57 | - |
Forward PE | - | 20.30 | 62.74 | 40.00 | - | - |
PS Ratio | 1.62 | 1.75 | 2.61 | 4.73 | 6.12 | - |
PB Ratio | 2.20 | 2.37 | 3.29 | 5.55 | 5.11 | - |
P/TBV Ratio | 3.13 | 3.08 | 4.24 | 6.96 | 5.20 | - |
P/FCF Ratio | 12.70 | 15.38 | - | - | - | - |
P/OCF Ratio | 7.53 | 8.99 | 18.26 | 20.94 | 33.08 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.14 | 2.29 | 3.09 | 5.08 | 6.17 | - |
EV/EBITDA Ratio | 11.72 | 22.95 | 38.81 | 30.56 | 65.64 | - |
EV/EBIT Ratio | 31.05 | 47.06 | 93.08 | 38.29 | 115.21 | - |
EV/FCF Ratio | 16.79 | 20.10 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.94 | 0.94 | 0.91 | 0.80 | 0.62 | 1.15 |
Debt / EBITDA Ratio | 3.78 | 4.16 | 4.75 | 2.93 | 4.14 | 3.09 |
Debt / FCF Ratio | 5.42 | 6.08 | - | - | - | 10.46 |
Net Debt / Equity Ratio | 0.69 | 0.73 | 0.67 | 0.44 | 0.17 | 0.97 |
Net Debt / EBITDA Ratio | 4.29 | 5.40 | 6.67 | 2.26 | 2.14 | 3.97 |
Net Debt / FCF Ratio | 4.00 | 4.73 | -8.86 | -82.36 | -39.93 | 8.83 |
Asset Turnover | 0.63 | 0.61 | 0.57 | 0.64 | 0.57 | 0.98 |
Inventory Turnover | 8.06 | 9.45 | 10.42 | 10.99 | 9.39 | 10.59 |
Quick Ratio | 0.71 | 0.72 | 0.77 | 0.99 | 1.81 | 0.60 |
Current Ratio | 0.99 | 0.99 | 0.97 | 1.17 | 2.04 | 0.86 |
Return on Equity (ROE) | 0.97% | -2.56% | -4.18% | 12.68% | 1.36% | 10.42% |
Return on Assets (ROA) | 2.70% | 1.86% | 1.18% | 5.30% | 1.93% | 6.35% |
Return on Invested Capital (ROIC) | 1.40% | -16.41% | 2.58% | 9.61% | 1.50% | 9.64% |
Return on Capital Employed (ROCE) | 5.40% | 3.70% | 2.40% | 9.60% | 3.00% | 9.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.26% | -1.24% | -1.46% | 2.08% | 0.19% | - |
FCF Yield | 7.88% | 6.50% | -2.30% | -0.10% | -0.08% | - |
Dividend Yield | 1.88% | - | - | 0.47% | 0.14% | - |
Payout Ratio | 150.08% | - | - | 10.31% | 43.96% | 4.85% |
Buyback Yield / Dilution | -0.97% | 0.80% | -0.08% | -16.43% | -15.01% | 0.39% |
Total Shareholder Return | 0.91% | 0.80% | -0.08% | -15.96% | -14.87% | 0.39% |